Conferences, Videos & Podcasts
Respiri crosses off new milestones to deliver Wheezo to respiratory illness patients in U.S.
Proactive Investors, 23 February 2023
Proactive Investors, 23 February 2023
Respiri - executive interview
Edison, 22 September 2022
Edison, 22 September 2022
Broker Briefing Tech & Biotech Investor Webinar, March 2022
Peter Switzer CEO Masterclass, 2 March 2022
Respiri Limited Investor Webinar, February 2022
Respiri Presentation – NWR Virtual Investor Conference (Series 8)
Respiri Shareholder Update, September 2020
Respiri (ASX:RSH) Presentation, FNN Online Investor Event, September 2020
Conference Call held on Friday 17th January 2020
This interview first appeared on Eureka Report as has been republished with permission